Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Insight Brief
November 10, 2016

Advancing Precision Medicine through Anatomic Pathology

Tissue-based Molecular Testing and Companion Diagnostics
In today’s challenging economic environment, it is more important than ever for a drug manufacturer to predict the successful outcome of a clinical trial. It is now proven that clinical trials incorporating biomarker selection have a greater probability of success across all stages of clinical development. Download our complimentary insight brief to learn more.

Authors:
Radha Krishnan, Chief Pathologist and Senior Medical Director, Q2 Solutions
Jacqueline Coleman, Scientific Advisor, Molecular and Targeted Genetics Testing, Q2 Solutions